Thursday, July 9, 2026

biotech · Cervical Spinal Cord Injury · Spinal Cord Injury · LCTX

Lineage Cell Therapeutics

Lineage Cell Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Carlsbad, USA HQ
1990 Founded
35 Employees
Public company Type
LCTX · NYSE Ticker
Company details
Status
Public
HQ
Carlsbad, USA
Founded
1990
Employees
35
Programs
3
Drugs
0
Patents
0
Intelligence · Drug Pipeline

Lineage Cell Therapeutics pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Lineage Cell Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →